patients

Scientists identify genetic variant causing ALS in some patients

Scientists identify genetic variant causing ALS in some patients

Researchers from Nagoya University in Japan have identified a new genetic variant found in some patients with amyotrophic lateral sclerosis (ALS). Using human induced pluripotent stem (iPS) cells, they detailed the process by which this variant relates to ALS. The researchers say they expect this mechanism to be a new therapeutic target for the treatment …

Scientists identify genetic variant causing ALS in some patients Read More »

Neurocrine Biosciences presents data on the demographic and clinical characteristics of pediatric patients with SCN8A-related epilepsy at AES 2022

Neurocrine Biosciences presents data on the demographic and clinical characteristics of pediatric patients with SCN8A-related epilepsy at AES 2022

SAN DIEGO, December 2, 2022 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX), a leading neuroscience-focused biopharmaceutical company, today released demographic and clinical data from studies based on genetic screening of children with SCN8A– related epilepsies. Data was collected from over 17,000 patients through Invitee Corporation’s Behind the SeizureĀ® Program, of which Neurocrine Biosciences is a …

Neurocrine Biosciences presents data on the demographic and clinical characteristics of pediatric patients with SCN8A-related epilepsy at AES 2022 Read More »